What are the salvage therapy options for small cell lung cancer?

The Implications of Recent Datasets for the Current and Future Management of Lung CancerПодробнее

How do you select appropriate therapy for ALK positive NSCLC in the first-line setting?Подробнее

Patient Success Stories: Metastatic Non-Small Cell Lung Cancer, Ramaswamy Govindan MDПодробнее

Assessing Advancements in Treatment Options for Small Cell Lung CancerПодробнее

Lung Cancer Conclave 08 DecПодробнее

CAR T-Cell Therapy as Early Treatment for Multiple Myeloma - Blood Cancers Video LibraryПодробнее

Current Management of Stage IIIA Non-Small Cell Lung Cancer: A Changing Paradigm (November 10, 2022)Подробнее

Watch Drs. Socinski & Nieva discuss NCSLC Immunotherapy - visit: https://bit.ly/3k7g96tПодробнее

CASPIAN Trial: Durvalumab and Chemotherapy in ES-SCLCПодробнее

Salvage Therapy Options for mCRCПодробнее

Changing Realities in Treating mCRCПодробнее

Goals in Previously Treated Advanced Renal Cell CarcinomaПодробнее

Mono & Polytherapy Options for Relapse & ProspectsПодробнее

Frontline Treatment Options & Chemotherapy ResponseПодробнее

Medicine Grand Rounds: Immunotherapy in Lung Cancer 1/16/18Подробнее

Options for mRCC After NivolumabПодробнее

Emerging Therapeutic Options for Relapsed/Refractory Multiple MyelomaПодробнее

Therapeutic Algorithm for NSCLC AdenocarcinomaПодробнее

Current Treatment Landscape for NSCLCПодробнее